Evidence map›Paper›PMID 38339157›Full record

ArticleInternational journal of molecular sciences2024

YTHDF1's Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network.

Wenting Luo, Youjia Zhou, Jiayang Wang, Keqin Wang, Qing Lin, Yuqiu Li, Yujie Xie, Miao Li, Jie Wang, Lixia Xiong

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular Research and Treatment of Breast Cancer 2.0.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wenting LuoDepartment of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.
Youjia ZhouDepartment of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.
Jiayang WangFirst Clinical Medical College, Nanchang University, Nanchang 330006, China.
Keqin WangFirst Clinical Medical College, Nanchang University, Nanchang 330006, China.
Qing LinDepartment of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.
Yuqiu LiQueen Mary School, Nanchang University, Nanchang 330006, China.
Yujie XieCollege of Pharmacy, Nanchang University, Nanchang 330006, China.
Miao LiSecond Clinical Medical College, Nanchang University, Nanchang 330006, China.
Jie WangKey Laboratory of Functional and Clinical Translational Medicine, Xiamen Medical College, Fujian Province University, Xiamen 361023, China.
Lixia XiongDepartment of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.ORCID 0000-0003-3769-2496
Nanchang University · CN

Funding

Key laboratory of functional and clinical translational medicine, Fujian province university No. XMMC-FCTM202103Key Project of Jiangxi Provincial Natural Science Foundation No. 20212ACB206040National Natural Science Foundation of China No. 31860317, No. 32160169the college students innovation training program of Nanchang University No. S202210403004
6 · The paper itself

Abstract

YTH N

Indexed as

Breast NeoplasmsMicroRNAsRNA-Binding ProteinsBlotting, WesternHumansNeoplasmsRNA, AntisenseRNA, Competitive EndogenousTumor MicroenvironmentMicroRNAsRNA, AntisenseRNA-Binding ProteinsRNA, Competitive EndogenousYTHDF1 protein, humanbreast cancerceRNAimmunitym6AprognosisYTHDF1

Identifiers

PMID38339157
PMCPMC10856278
OpenAlexW4391533512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.